Sergio Jacinto
Neurology with Special Qualifications in Child Neurology · Tampa, FLNPI 1558394114
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $18,684 of the $21,027 with a category attached, or 88.9%. It is spread thinly across 46 manufacturers, the largest accounting for just 18.4% — the pattern of someone who eats at a lot of different presentations.
Across 898 payments — averaging $23.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Livanova USA, Inc.$4K
- UCB, Inc.$3K
- Ironshore Pharmaceuticals Inc.$2K
- Sunovion Pharmaceuticals Inc.$1K
- Supernus Pharmaceuticals, Inc.$1K
- Eisai Inc.$1K
- plus $9K from 40 others
What the payments were for
- Travel & lodging$2,34211%
- Food & beverage$18,68489%
- Education$10%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VNS Therapy$3,335
- Fycompa$716
- APTIOM$603
- Fintepla$496
- VNS THERAPY SENTIVA MODEL 1000 GENERATOR$393
- Epidiolex$300
- QELBREE$254
- AQNEURSA$139
- Dynasplint$133
- Jornay PM 20mg capsules (Bottle of 100)$125
- Cenobamate$125
- VALTOCO$124
- DAYBUE$123
- ACTHAR$122
- XCOPRI$119
- ZTALMY$119
- Azstarys$114
How this compares
$21,027 in reported general payments places this provider in the 80th percentile of 137 neurology with special qualifications in child neurology providers in Florida.
See all neurology with special qualifications in child neurology providers in Florida →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OnfiClobazam | 24 | $48,713 |
| KeppraLevetiracetam | 31 | $32,259 |
| VimpatLacosamide | 15 | $7,376 |
| Levetiracetam | 11 | $472 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| UCB, Inc.Vimpat | $2,512 | $7,37615 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 137 neurology with special qualifications in child neurology providers in Florida.
Other neurology with special qualifications in child neurology in Tampa
- Jose FerreiraTampa$88K
- Eric VernierTampa$33K
- Anne CsereTampa$29K
- Jose ForadadaTampa$13K
- Ernesto MillanTampa$11K
- Sagarika NalluTampa$7K
- Paul WinnerWest Palm Beach$624K
- Omer Abdul HamidOrlando$283K
- Natalie GillsonFort Myers$250K
- Trevor ResnickMiami$230K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.